Parametric Risk Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Parametric Risk Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$8.74M	Hold	190,000	–	–	0.59%	31
2016 Q2	$9.54M	Hold	190,000	–	–	0.63%	35
2016 Q1	$10.2M	Buy	190,000 +30,000	+19%	+$1.76M	0.69%	28
2015 Q4	$10.5M	Buy	160,000 +115,000	+256%	+$7.11M	0.73%	23
2015 Q3	$2.54M	Hold	45,000	–	–	0.16%	66
2015 Q2	$2.66M	Hold	45,000	–	–	0.18%	68
2015 Q1	$2.8M	Buy	+45,000	New	+$2.62M	0.19%	69

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Parametric Risk Advisors's TEVA Position: Q3 2016 in Review

Parametric Risk Advisors held its Teva Pharmaceuticals (TEVA) position steady in Q3 2016 at 190,000 shares worth $8.74M. The position accounts for 0.59% of the portfolio, ranked #31.

Parametric Risk Advisors first reported a position in TEVA in Q1 2015 and has held it in 7 quarters since. The position peaked at $10.5M in Q4 2015. 795 funds tracked by Wall St. Rank hold TEVA as of Q3 2016.

Parametric Risk Advisors held 190,000 shares of Teva Pharmaceuticals worth $8.74M as of Q3 2016.
Parametric Risk Advisors left its Teva Pharmaceuticals share count unchanged in Q3 2016.
Teva Pharmaceuticals made up 0.59% of Parametric Risk Advisors's portfolio in Q3 2016, its #31 holding.
Parametric Risk Advisors first reported a position in Teva Pharmaceuticals in Q1 2015 and has held it in 7 quarters since.
Parametric Risk Advisors's Teva Pharmaceuticals position peaked at $10.5M in Q4 2015.
795 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2016.

Based on Parametric Risk Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.